Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BlackRock Inc. BLK | 396,473 6.000% | 396,473 (New Position) | Filing History |
| 2022-02-04 10:54 am Purchase | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | FRANKLIN RESOURCES INC BEN | 337,267 5.100% | 337,267 (New Position) | Filing History |
| 2021-04-29 10:17 am Purchase | 2021-03-26 | 13D | VistaGen Therapeutics, Inc. VTGN | Growth Equity Opportunities 17, LLC | 543,420 8.600% | 231,420 (+74.17%) | Filing History |
| 2021-03-22 06:06 am Purchase | 2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% | 165,499 (+66.20%) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 474,675 9.990% | 474,675 (New Position) | Filing History |
| 2021-02-16 06:14 am Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% | 250,000 (New Position) | Filing History |